BACKGROUND: A new nucleic acid-based assay (simple amplification-based assay [SAMBA]) for rapid visual detection of human immunodeficiency virus-type 1 (HIV-1) by dipstick is described. The assay was designed to be simple, stable, robust, self-contained, and capable of detecting a broad spectrum of HIV-1 subtypes and recombinant forms. METHODS: The performance of the SAMBA HIV-1 test (amplification and detection chemistry) was evaluated using the World Health Organization HIV-1 RNA Genotype Reference Panel, with clinical samples representing various viral subtypes and recombinant forms common in sub-Saharan Africa. Sixty-nine randomly selected and blinded clinical samples that had undergone HIV-1 genotypic resistance analyses in a large London teaching hospital were also tested. These samples included 14 different viral subtypes or recombinant forms with viral loads of 78-9.5 x 10(6) copies/mL. RESULTS: The sensitivity and viral subtype coverage of the SAMBA HIV-1 test were either comparable to or better than those of the commercially available nucleic acid-based HIV-1 diagnostic tests. CONCLUSIONS: The unique characteristics and competitive performance of the SAMBA HIV-1 test render it suitable for point-of-care and near-patient testing in both developed and developing countries.
BACKGROUND: A new nucleic acid-based assay (simple amplification-based assay [SAMBA]) for rapid visual detection of human immunodeficiency virus-type 1 (HIV-1) by dipstick is described. The assay was designed to be simple, stable, robust, self-contained, and capable of detecting a broad spectrum of HIV-1 subtypes and recombinant forms. METHODS: The performance of the SAMBA HIV-1 test (amplification and detection chemistry) was evaluated using the World Health Organization HIV-1 RNA Genotype Reference Panel, with clinical samples representing various viral subtypes and recombinant forms common in sub-Saharan Africa. Sixty-nine randomly selected and blinded clinical samples that had undergone HIV-1 genotypic resistance analyses in a large London teaching hospital were also tested. These samples included 14 different viral subtypes or recombinant forms with viral loads of 78-9.5 x 10(6) copies/mL. RESULTS: The sensitivity and viral subtype coverage of the SAMBA HIV-1 test were either comparable to or better than those of the commercially available nucleic acid-based HIV-1 diagnostic tests. CONCLUSIONS: The unique characteristics and competitive performance of the SAMBA HIV-1 test render it suitable for point-of-care and near-patient testing in both developed and developing countries.
Authors: Sikhulile Moyo; Terence Mohammed; Kathleen E Wirth; Melanie Prague; Kara Bennett; Molly Pretorius Holme; Lucy Mupfumi; Philemon Sebogodi; Natasha O Moraka; Corretah Boleo; Comfort N Maphorisa; Boitumelo Seraise; Simani Gaseitsiwe; Rosemary M Musonda; Erik van Widenfelt; Kathleen M Powis; Tendani Gaolathe; Eric J Tchetgen Tchetgen; Joseph M Makhema; Max Essex; Shahin Lockman; Vladimir Novitsky Journal: J Clin Microbiol Date: 2016-10-12 Impact factor: 5.948
Authors: Benjamin P Sullivan; Andrew T Bender; Duy N Ngyuen; Jane Yuqian Zhang; Jonathan D Posner Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2020-12-13 Impact factor: 3.205
Authors: Laura G Wesolowski; Kelly Wroblewski; Spencer B Bennett; Monica M Parker; Celia Hagan; Steven F Ethridge; Jeselyn Rhodes; Timothy J Sullivan; Imelda Ignacio-Hernando; Barbara G Werner; S Michele Owen Journal: J Clin Virol Date: 2015-01-24 Impact factor: 3.168
Authors: Bharat S Parekh; Chin-Yih Ou; Peter N Fonjungo; Mireille B Kalou; Erin Rottinghaus; Adrian Puren; Heather Alexander; Mackenzie Hurlston Cox; John N Nkengasong Journal: Clin Microbiol Rev Date: 2018-11-28 Impact factor: 26.132
Authors: Kelly A Curtis; Donna L Rudolph; Daphne Morrison; Dylan Guelig; Steven Diesburg; David McAdams; Robert A Burton; Paul LaBarre; Michele Owen Journal: J Virol Methods Date: 2016-09-08 Impact factor: 2.014